Comparison of the effect of herbal laxative drug Golgand and PEG syrup on children's performance: a randomized, single-blind clinical trial study

Comparison of the Effect of Herbal Laxative (Goleghand) and PEG Syrup in Functional Constipation on children referred to medical centers of Fasa University of Medical Sciences( A single-blind randomized Controlled clinical trial study)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240730062585N1

Enrollment

Registered

2024-08-16

Start date

2024-08-22

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation. constipation

Interventions

Intervention 1: Intervention group: Group (group A): PEG 4000 will be given in the form of syrup at a dose of 0.7 g/kg twice a day for 8 weeks. All explanations about how to use and side effects and d

Eligibility

Sex/Gender

All

Age

2 Years to 15 Years

Inclusion criteria

Inclusion criteria: Children aged 2-15 years with non-organic constipation according to Rome IV criteria Not having an allergy to medicinal plants Not taking laxatives 2 weeks ago Not having underlying digestive diseases No history of gastrointestinal surgery

Exclusion criteria

Exclusion criteria: Children diagnosed with IBS Receiving treatment for constipation within 2 weeks before entering the study Children with mental retardation or metabolic disease Children with Hirschirong or spinal anomaly or anorectal pathology Children who have undergone intestinal or stomach surgery The occurrence of sensitivity during the treatment period

Design outcomes

Primary

Measure	Time frame
Constipation score in the evaluation of constipation. Timepoint: Before and after the intervention. Method of measurement: Bristol Stool Form Survey (BSFS).;Constipation rate. Timepoint: 8 weeks after the start of the intervention. Method of measurement: Bristol Stool Form Survey (BSFS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDorna Rahdar

Fasa University of Medical Sciences

dr.rahdar54@gmail.com+98 71 5335 0994

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026